BIOCLINICA INC (BIOC) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 249 transactions totaling $2.0M, demonstrating a bullish sentiment with $1.8M in net insider flow. The most recent transaction on Dec 9, 2021 involved a sale of 363 shares valued at $1.5K.
No significant insider buying has been recorded for BIOC in the recent period.
No significant insider selling has been recorded for BIOC in the recent period.
Based on recent SEC filings, insider sentiment for BIOC is bullish with an Insider Alignment Score of 94/100 and a net flow of $1.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIOCLINICA INC (BIOC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading BIOC stock, having executed 249 transactions in the past 90 days. The most active insider is Claire Reiss (Executive), who has made 5 transactions totaling $7.8M.
Get notified when executives and directors at BIOC file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | F. Hale David | Executive | Sale | 363 | $4.06 | $1.5K | |
| Dec 9, 2021 | F. Hale David | Executive | Sale | 11 | $4.07 | $45 | |
| Dec 9, 2021 | F. Hale David | Executive | Sale | 71 | $4.07 | $289 | |
| Jun 12, 2020 | F. Hale David | Executive | Sale | 445 | $0.55 | $245 | |
| Jun 12, 2020 | F. Hale David | Executive | Sale | 159 | $0.56 | $89 | |
| Jun 12, 2020 | F. Hale David | Executive | Sale | 556 | $0.56 | $311 | |
| Jan 30, 2018 | Gerhardt Bruce | Executive | Purchase | 25,000 | $N/A | $0 | |
| May 31, 2017 | W. Nall Michael | Executive | Award | 50,000 | $N/A | $0 | |
| May 31, 2017 | Kennedy Timothy | Executive | Award | 25,000 | $N/A | $0 | |
| May 31, 2017 | J. Arnold Lyle | Executive | Award | 25,000 | $N/A | $0 | |
| May 31, 2017 | Singh Veena | Executive | Award | 25,000 | $N/A | $0 | |
| Jan 19, 2017 | Yu Fan | Executive | Disposition | 254,893 | $1.10 | $280.4K | |
| Jan 18, 2017 | Yu Fan | Executive | Disposition | 549,708 | $1.10 | $604.7K | Large |
| Jan 17, 2017 | Yu Fan | Executive | Disposition | 876,399 | $1.10 | $964.0K | Large |
| Oct 19, 2016 | F. Hale David | Executive | Purchase | 90,909 | $1.10 | $100.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 12 | $11.7M | 44.0% |
Conversion(C) | 8 | $8.6M | 32.2% |
Purchase(P) | 36 | $1.9M | 7.3% |
Disposition(D) | 3 | $1.8M | 7.0% |
Award(A) | 80 | $1.1M | 4.3% |
Payment(F) | 51 | $765.4K | 2.9% |
Exercise(M) | 38 | $489.2K | 1.8% |
Sale(S) | 10 | $114.0K | 0.4% |
Gift(G) | 10 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at BIOCLINICA INC are accumulating shares at an accelerated pace. With 27 insiders making 249 transactions totaling $1.9M in purchases versus $114.0K in sales, the net buying activity of $1.8M signals strong executive confidence. Claire Reiss (Executive) leads the buying activity with $7.8M in transactions across all time.